Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2):: divergent modulating effects on body mass index in obese and lean Caucasian men

被引:166
作者
Ek, J
Urhammer, SA
Sorensen, TIA
Andersen, T
Auwerx, J
Pedersen, O
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Copenhagen, Denmark
[2] Hagedorn Res Inst, Copenhagen, Denmark
[3] Inst Prevent Med, Danish Epidemiol Sci Ctr, Copenhagen, Denmark
[4] Roskilde Cty Hosp, Roskilde, Denmark
[5] Inst Pasteur, Dept Athesclerosis, INSERM, U325, F-59019 Lille, France
关键词
PPAR-gamma; 2; mutations; obesity; body mass index changes; epidemiology;
D O I
10.1007/s001250051243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. The objectives of the present investigation were to examine: 1) whether a Pro115Gln variant in the peroxisome proliferator-activated receptor-gamma 2 (PPAR-gamma 2) is associated with juvenile-onset obesity among Danish Caucasianmen and 2) whether the relation of a Pro12Ala polymorphism in PPAR-gamma 2 with BMI and long-term weight regulation differ between lean and obese subjects within the same cohort. Methods. The Pro115Gln and Pro112Aln variants were examined using PCR and RFLP in a group of 752 subjects with a Body Mass Index (BMI) of 31.0 kg/m(2) or more and in 869 non-obese control subjects. Results. We did not find Pro115Gln in any of the 1621 male subjects we examined. Among the males with juvenile-onset obesity, the allelic frequency of the Pro12Ala polymorphism was 14% (95% confidence interval: 12-16%) compared with 16% (14-17%) among the non-obese control subjects (NS). Heterozygosity of the codon 12 variant was not associated with differences in BMI or changes in body weight regulation during follow up in lean or obese subjects. In the group of obese subjects, 21 homozygous Ala12Ala carriers had, however, a higher BMI (38.9 +/- 5.4 kg/m(2) (means +/- SD) vs 35.5 +/- 5.5 kg/m(2), p = 0.008) and a higher weight gain (0.27 +/- 0.24 kg.m(-2).year(-1) vs 0.10 +/- 0.24 kg.m(-2).year(-1), p = 0.004), compared with wild-type carriers. Moreover, within the control group of 869 men the 14 homozygous carriers of the variant had a lower BMI (24.4 +/- 2.7 kg/m(2) vs 26.2 +/- 3.7 kg/m(2), p = 0.005) and a slower increase in BMI (0.11 +/- 0.11 kg.m(-2).year(-1) vs 0.17 +/- 0.11 kg.m(-2).year(-1), p = 0.002) compared with wild-type carriers. Conclusion/interpretation. The codon 12 variant of PPAR-gamma 2 is not intrinsically associated with juvenile obesity. The variant may in its homozygous form interact, however, with various combinations of genetic and environmental factors in lean and obese subjects to cause divergent modulating effects on BMI and long-term body weight control.
引用
收藏
页码:892 / 895
页数:4
相关论文
共 10 条
  • [1] Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
    Beamer, BA
    Yen, CJ
    Andersen, BE
    Muller, D
    Elahi, D
    Cheskin, LJ
    Andres, R
    Roth, J
    Shuldiner, AR
    [J]. DIABETES, 1998, 47 (11) : 1806 - 1808
  • [2] A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
    Deeb, SS
    Fajas, L
    Nemoto, M
    Pihlajamäki, J
    Mykkänen, L
    Kuusisto, J
    Laakso, M
    Fujimoto, W
    Auwerx, J
    [J]. NATURE GENETICS, 1998, 20 (03) : 284 - 287
  • [3] Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2
    Elbrecht, A
    Chen, YL
    Cullinan, CA
    Hayes, N
    Leibowitz, MD
    Moller, DE
    Berger, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) : 431 - 437
  • [4] The organization, promoter analysis, and expression of the human PPAR gamma gene
    Fajas, L
    Auboeuf, D
    Raspe, E
    Schoonjans, K
    Lefebvre, AM
    Saladin, R
    Najib, J
    Laville, M
    Fruchart, JC
    Deeb, S
    VidalPuig, A
    Flier, J
    Briggs, MR
    Staels, B
    Vidal, H
    Auwerx, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18779 - 18789
  • [5] Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
    Ristow, M
    Müller-Wieland, D
    Pfeiffer, A
    Krone, W
    Kahn, CR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) : 953 - 959
  • [6] SONNEHOLM S, 1989, INT J OBESITY, V14, P319
  • [7] Peroxisome proliferator-activated receptor gene expression in human tissues - Effects of obesity, weight loss, and regulation by insulin and glucocorticoids
    VidalPuig, AJ
    Considine, RV
    JimenezLinan, M
    Werman, A
    Pories, WJ
    Caro, JF
    Flier, JS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) : 2416 - 2422
  • [8] Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPAR gamma) - Differential activity of PPAR gamma 1 and -2 isoforms and influence of insulin
    Werman, A
    Hollenberg, A
    Solanes, G
    Bjorbaek, C
    VidalPuig, AJ
    Flier, JS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) : 20230 - 20235
  • [9] CONDITIONAL ECTOPIC EXPRESSION OF C/EBP-BETA IN NIH-3T3 CELLS INDUCES PPAR-GAMMA AND STIMULATES ADIPOGENESIS
    WU, ZD
    XIE, YH
    BUCHER, NLR
    FARMER, SR
    [J]. GENES & DEVELOPMENT, 1995, 9 (19) : 2350 - 2363
  • [10] Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians:: Identification of a Pro12Ala PPARγ2 missense mutation
    Yen, CJ
    Beamer, BA
    Negri, C
    Silver, K
    Brown, KA
    Yarnall, DP
    Burns, DK
    Roth, J
    Shuldiner, AR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (02) : 270 - 274